Novartis AG Deferred Tax Liabilities
Novartis AG (NVSEF) had Deferred Tax Liabilities of $3.40 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilities · last filed 2026-02-04
- 2025-12-31: Deferred Tax Liabilities $3.40B.
- 2025-06-30: Deferred Tax Liabilities $2.32B.
- 2024-12-31: Deferred Tax Liabilities $2.42B.
- 2024-06-30: Deferred Tax Liabilities $2.46B.
| Period end | Deferred Tax Liabilities | Deferred Tax Liabilities as first filed |
|---|---|---|
| 2025-12-31 | $3.40B 20-F · filed 2026-02-04 | |
| 2025-06-30 | $2.32B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $2.42B 20-F · filed 2026-02-04 | |
| 2024-06-30 | $2.46B 6-K · filed 2024-07-18 | |
| 2023-12-31 | $2.25B 20-F · filed 2025-01-31 | |
| 2023-06-30 | $2.53B 6-K · filed 2023-07-18 | |
| 2022-12-31 | $2.69B 20-F · filed 2024-01-31 | |
| 2022-06-30 | $3.12B 6-K · filed 2022-07-19 | |
| 2021-12-31 | $3.07B 20-F/A · filed 2023-05-15 | |
| 2021-06-30 | $7.47B 6-K · filed 2021-07-21 | |
| 2020-12-31 | $3.14B 20-F · filed 2022-02-02 | $7.42B 20-F · filed 2021-01-26 |
| 2020-06-30 | $7.50B 6-K · filed 2020-07-21 | |
| 2019-12-31 | $5.87B 20-F · filed 2021-01-26 | |
| 2019-06-30 | $5.72B 6-K · filed 2019-07-18 | |
| 2018-12-31 | $7.47B 20-F · filed 2020-01-29 | |
| 2018-06-30 | $7.63B 6-K · filed 2018-07-18 | |
| 2018-01-01 | $5.18B 20-F · filed 2019-01-30 | |
| 2017-12-31 | $5.17B 20-F · filed 2019-01-30 | |
| 2016-12-31 | $6.66B 6-K · filed 2018-01-24 |